Deepverge PLC DeepVerge Investor Presentation

TIDMDVRG

Deepverge PLC

25 March 2021

25 Mar 2021

DeepVerge PLC

("DeepVerge" or "Company")

DeepVerge Investor Presentation

Project Updates on Labskin, Modern Water, Skin Trust Club and Microsaic Agreement

DeepVerge (LSE:DVRG.L), the environmental and life science AI company , announces that, DeepVerge (LSE:DVRG.L), the environmental and life science AI company , announces that, is pleased to announce that Gerry Brandon, CEO will provide a live presentation relating to Project Updates - Labskin, Skin Trust Club, Modern Water - Wastewater & Breath Test via the Investor Meet Company platform on 31st Mar 2021 at 1:30pm BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet DEEPVERGE PLC via:

https://www.investormeetcompany.com/deepverge-plc/register-investor

Investors who already follow DEEPVERGE PLC on the Investor Meet Company platform will automatically be invited.

 
                                                   [phone] 
 DeepVerge plc              Gerry Brandon           648 
 
 SPARK Advisory Partners 
  Limited                   Neil Baldwin/Andrew    [phone] 
  (Nominated Adviser)        Emmott                 8974 
 
 Turner Pope Investments    Andy Thacker/Zoe       [phone] 
  (TPI) Limited (Broker)     Alexander              0050 
 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments and the data they generate, for the analysis and identification of bacteria, virus and toxins. DeepVerge is utilising artificial intelligent data analytics to prove scientifically the impact of skincare product claims on the skin microbiome for clients including most of the top 20 global cosmetic companies and to detect remotely, and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

About Microsaic (www.microsaic.com)

Microsaic floated on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested c.GBP30m over 20 years of development, Microsaic has a robust and innovative patent portfolio in cutting-edge technology designed and developed for "Industry 4.0" application. Microsaic serves markets in Human Health, Environmental Health and Diversified Industries. Microsaic's system solutions enable analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection data at multiple steps in the process workflow.

Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point of need applications.

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAEELFLFXLZBBL

(END) Dow Jones Newswires

March 25, 2021 11:43 ET (15:43 GMT)